Evidence map›Paper›PMID 8058733›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1994

Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo.

H Soreq, D Patinkin, E Lev-Lehman, M Grifman, D Ginzberg, F Eckstein, H Zakut

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Acetylcholinesterase and human cancers.Advances in cancer research · 2021
    Review
  4. Review
  5. Review
  6. Non-synaptic roles of acetylcholinesterase and agrin.Journal of molecular neuroscience : MN · 2014
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Acetylcholinesterase in Hirschsprung's disease.Pediatric surgery international · 2005
    Review
  14. Article
  15. Morphogenetic roles of acetylcholine.Environmental health perspectives · 1999
    Review
  16. Review
  17. Article
  18. Article
  19. Inhibition of gene expression with ribozymes.Cellular and molecular neurobiology · 1994
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

H SoreqDepartment of Biological Chemistry, Hebrew University of Jerusalem, Israel.
D Patinkin
E Lev-Lehman
M Grifman
D Ginzberg
F Eckstein
H Zakut
Hebrew University of Jerusalem · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To examine the role of acetylcholinesterase (EC 3.1.1.7) in hematopoietic cell proliferation and differentiation, we administered a 15-mer phosphorothioate oligonucleotide, antisense to the corresponding ACHE gene (AS-ACHE), to primary mouse bone marrow cultures. Within 2 hr of AS-ACHE addition to the culture, ACHE mRNA levels dropped by approximately 90%, as compared with those in cells treated with the "sense" oligomer, S-ACHE. Four days after AS-ACHE treatment, ACHE mRNA increased to levels 10-fold higher than in S-ACHE cultures or in fresh bone marrow. At this later time point, differential PCR display revealed significant differences between cellular mRNA transcripts in bone marrow and those in AS-ACHE- or S-ACHE-treated cultures. These oligonucleotide-triggered effects underlay considerable alterations at the cellular level: AS-ACHE but not S-ACHE increased cell counts, reflecting enhanced proliferation. In the presence of erythropoietin it also enhanced colony counts, reflecting expansion of progenitors. AS-ACHE further suppressed apoptosis-related fragmentation of cellular DNA in the progeny cells, and it diverted hematopoiesis toward production of primitive blasts and macrophages in a dose-dependent manner promoted by erythropoietin. These findings suggest that the hematopoietic role of acetylcholinesterase, anticipated to be inverse to the observed antisense effects, is to reduce proliferation of the multipotent stem cells committed to erythropoiesis and megakaryocytopoiesis and macrophage production and to promote apoptosis in their progeny. Moreover, these findings may explain the tumorigenic association of perturbations in ACHE gene expression with leukemia.

Indexed as

AcetylcholinesteraseAnimalsApoptosisBase SequenceBone Marrow CellsCell DifferentiationCells, CulturedColony-Forming Units AssayDNA-Binding ProteinsEnzyme InductionErythroid-Specific DNA-Binding FactorsErythropoietinGene ExpressionHematopoietic Stem CellsInterleukin-3KineticsAcetylcholinesteraseDNA-Binding ProteinsErythroid-Specific DNA-Binding FactorsErythropoietinInterleukin-3Oligonucleotides, AntisenseRNA, MessengerTranscription Factors

Identifiers

PMID8058733
PMCPMC44513
OpenAlexW1971133960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.